{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T16:05:12Z","timestamp":1770912312096,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.jpba.2011.12.032","type":"journal-article","created":{"date-parts":[[2012,1,4]],"date-time":"2012-01-04T16:24:05Z","timestamp":1325694245000},"page":"42-47","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Chiral recognition of dapoxetine enantiomers with methylated-gamma-cyclodextrin: A validated capillary electrophoresis method"],"prefix":"10.1016","volume":"62","author":[{"given":"G\u00e1bor","family":"Neumajer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tam\u00e1s","family":"Sohajda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e1s","family":"Darcsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerg\u0151","family":"T\u00f3th","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lajos","family":"Szente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9la","family":"Nosz\u00e1l","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Szabolcs","family":"B\u00e9ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2011.12.032_bib0005","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/sj.ijir.3901099","article-title":"Premature to early ejaculation: a sampling of manuscripts regarding the most common male sexual dysfunction published in the IJIR: The Journal of Sexual Medicine","volume":"15","author":"Goldstein","year":"2003","journal-title":"Int. J. Impot. Res."},{"key":"10.1016\/j.jpba.2011.12.032_bib0010","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2147\/tcrm.2007.3.2.277","article-title":"Dapoxetine, a novel selective serotonin transport inhibitor for the treatment of premature ejaculation","volume":"3","author":"Kendirci","year":"2007","journal-title":"Ther. Clin. Risk Manage."},{"key":"10.1016\/j.jpba.2011.12.032_bib0015","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0091-3057(81)90023-X","article-title":"Effects of a new type of 5-HT receptor agonist on male rat sexual behavior","volume":"15","author":"Ahlenius","year":"1981","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jpba.2011.12.032_bib0020","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/01.ju.0000132159.61156.ea","article-title":"AUA guideline on the pharmacologic management of premature ejaculation","volume":"172","author":"Montague","year":"2004","journal-title":"J. Urol."},{"key":"10.1016\/j.jpba.2011.12.032_bib0025","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/0091270005284850","article-title":"Single- and multiple dose pharmacokinetics of dapoxetine hydrochloride, a novel agent for the treatment of premature ejaculation","volume":"46","author":"Modi","year":"2006","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2011.12.032_bib0030","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/jlcr.2580310406","article-title":"A chiral synthesis of dapoxetine hydrochloride, a serotonin reuptake inhibitor, and its 14C isotopomer","volume":"XXXI","author":"Wheeler","year":"1992","journal-title":"J. Label. Compd. Radiopharm."},{"key":"10.1016\/j.jpba.2011.12.032_bib0035","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1358\/dof.2004.029.12.865936","article-title":"Dapoxetine hydrochloride","volume":"29","author":"Sorbera","year":"2004","journal-title":"Drugs Future"},{"key":"10.1016\/j.jpba.2011.12.032_bib0040","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.tetasy.2006.02.022","article-title":"Lipase-catalyzed resolution of chiral 1,3-amino alcohols: application in the asymmetric synthesis of (S)-dapoxetine","volume":"17","author":"Torre","year":"2006","journal-title":"Tetrahedron"},{"key":"10.1016\/j.jpba.2011.12.032_bib0045","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/j.tetasy.2007.07.028","article-title":"Enantioselective synthesis of (S)-dapoxetine","volume":"18","author":"Siddiqui","year":"2007","journal-title":"Tetrahedron"},{"key":"10.1016\/j.jpba.2011.12.032_bib0050","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3998\/ark.5550190.0009.g28","article-title":"A stereoselective synthesis of (S)-dapoxetine starting from transcinnamyl alcohol","volume":"XVI","author":"Venkatesan","year":"2008","journal-title":"ARKIVOC"},{"key":"10.1016\/j.jpba.2011.12.032_bib0055","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/j.tet.2008.11.042","article-title":"An efficient formal synthesis of (S)-dapoxetine from enantiopure 3-hydroxy azetidin-2-one","volume":"65","author":"Chincholkar","year":"2009","journal-title":"Tetrahedron"},{"key":"10.1016\/j.jpba.2011.12.032_bib0060","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/adsc.200900676","article-title":"Stereoselective chemoenzymatic preparation of \u03b2-amino esters: molecular modelling considerations in lipase-mediated processes and application to the synthesis of (S)-dapoxetine","volume":"352","author":"Rodr\u00edguez-Mata","year":"2010","journal-title":"Adv. Synth. Catal."},{"key":"10.1016\/j.jpba.2011.12.032_bib0065","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1021\/jo902176s","article-title":"Highly efficient, enantioselective syntheses of (S)-(+)- and (R)-(\u2212)-dapoxetine starting with 3-phenyl-1-propanol","volume":"75","author":"Kang","year":"2010","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.jpba.2011.12.032_bib0070","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.bmc.2010.12.038","article-title":"Synthetic approaches to the 2009 new drugs","volume":"19","author":"Liu","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jpba.2011.12.032_bib0075","unstructured":"D.W. Robertson, D.T., Wong, D.C. Thompson, U.S. Patent 5 135 947 (1992)."},{"key":"10.1016\/j.jpba.2011.12.032_bib0080","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jpba.2009.06.005","article-title":"Isolation and structural elucidation of dapoxetine as an adulterant in a health supplement used for sexual performance enhancement","volume":"50","author":"Li","year":"2009","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2011.12.032_bib0085","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/BF02290245","article-title":"Chiral separation by capillary electrophoresis","volume":"34","author":"Kuhnl","year":"1992","journal-title":"Chromatographia"},{"key":"10.1016\/j.jpba.2011.12.032_bib0090","series-title":"Capillary Electrophoresis in Chiral Analysis","author":"Chankvetadze","year":"1997"},{"key":"10.1016\/j.jpba.2011.12.032_bib0095","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1002\/elps.200800081","article-title":"Strategies in method development to quantify enantiomeric impurities using CE","volume":"29","author":"Deeb","year":"2008","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jpba.2011.12.032_bib0100","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/BF02467710","article-title":"Experimental design methodologies to optimize the CE separation of epinephrine enantiomers","volume":"48","author":"Fanali","year":"1998","journal-title":"Chromatographia"},{"key":"10.1016\/j.jpba.2011.12.032_bib0105","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0021-9673(97)00912-6","article-title":"Orthogonal array design experiments for optimizing the separation of various pesticides by cyclodextrin-modified micellar electrokinetic chromatography","volume":"793","author":"He","year":"1998","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2011.12.032_bib0110","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jpba.2011.01.023","article-title":"Development and validation of a capillary electrophoresis method for the enantiomeric purity determination of RS86017 using experimental design","volume":"55","author":"Liu","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2011.12.032_bib0115","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/chir.530050414","article-title":"Use of cyclodextrins as chiral selectors for direct resolution of the enantiomers of fluoxetine and its metabolite norfluoxetine by HPLC","volume":"5","author":"Piperaki","year":"1993","journal-title":"Chirality"},{"key":"10.1016\/j.jpba.2011.12.032_bib0120","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0021-9673(95)00113-2","article-title":"Systematic approach to treatment of enantiomeric separations in capillary electrophoresis and liquid chromatography II. A study of the enantiomeric separation of fluoxetine and norfluoxetine","volume":"700","author":"Piperaki","year":"1995","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2011.12.032_bib0125","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1002\/(SICI)1522-2683(19991101)20:17<3432::AID-ELPS3432>3.0.CO;2-8","article-title":"Enantiomeric separation of fluoxetine and norfluoxetine in plasma and serum samples with high detection sensitivity capillary electrophoresis","volume":"20","author":"Desiderio","year":"1999","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jpba.2011.12.032_bib0130","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.japna.2003.08.013","article-title":"HPLC determination of sertraline in bulk drug, tablets and capsules using hydroxypropyl-beta-cyclodextrin as mobile phase additive","volume":"34","author":"Chen","year":"2004","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2011.12.032_bib0135","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jpba.2009.04.038","article-title":"Separation of stereoisomers of sertraline and its related enantiomeric impurities on a dimethylated beta-cyclodextrin stationary phase by HPLC","volume":"50","author":"Rao","year":"2009","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2011.12.032_bib0140","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ejps.2004.04.007","article-title":"NMR studies of the inclusion complex between \u03b2-cyclodextrin and paroxetine","volume":"22","author":"Bernini","year":"2004","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2011.12.032_bib0145","first-page":"830","article-title":"Separation of paroxetine and its intermediate enantiomers by high performance liquid chromatography using carboxy-methyl-\u03b2-cyclodextrin as chiral mobile phase additive","volume":"25","author":"Lu","year":"2007","journal-title":"Chin. J. Chromatogr."},{"key":"10.1016\/j.jpba.2011.12.032_bib0150","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1081\/JLC-120023251","article-title":"Chiral separation of fluoxetine and its analogs with charged cyclodextrins by capillary electrophoresis","volume":"26","author":"Inoue","year":"2003","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.jpba.2011.12.032_bib0155","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1002\/elps.200305481","article-title":"Infinite enantiomeric resolution of basic compounds using highly sulfated cyclodextrin as chiral selector in capillary electrophoresis","volume":"24","author":"Rudaz","year":"2003","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jpba.2011.12.032_bib0160","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1464-410X.2006.05911.x","article-title":"Pharmacokinetic and pharmacodynamic features of dapoxetine, a novel drug for \u2018on demand\u2019 treatment of premature ejaculation","volume":"97","author":"Andersson","year":"2005","journal-title":"B. J. U. Int."},{"key":"10.1016\/j.jpba.2011.12.032_bib0165","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0021-9673(95)00774-1","article-title":"Examination of the origin, variation, and proper use of expressions for the estimation of association constants by capillary electrophoresis","volume":"721","author":"Rundlett","year":"1996","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2011.12.032_bib0170","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0021-9673(01)88738-0","article-title":"Use of cyclodextrins in capillary zone electrophoresis: resolution of terbutaline and propranolol enantiomers","volume":"545","author":"Fanali","year":"1991","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.jpba.2011.12.032_bib0175","series-title":"International Conference on Harmonization","article-title":"Guideline Q2 (R1), validation of analytical procedures: text and methodology","year":"2005"},{"key":"10.1016\/j.jpba.2011.12.032_bib0180","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0731-7085(98)00203-9","article-title":"Robustness testing of a liquid chromatography method for the determination of vorozole and its related compounds in oral tablets","volume":"18","author":"Jimidar","year":"1998","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2011.12.032_bib0185","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0731-7085(00)00529-X","article-title":"Guidance for robustness\/ruggedness tests in method validation","volume":"24","author":"Heyden","year":"2001","journal-title":"J. Pharm. Biomed. Anal."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708511007394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708511007394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T03:51:04Z","timestamp":1543290664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708511007394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":37,"alternative-id":["S0731708511007394"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2011.12.032","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}